Piper Jaffray to Host 29th Annual Healthcare Conference
23 November 2017 - 7:08AM
Business Wire
Piper Jaffray Companies (NYSE: PJC), a leading investment bank
and asset management firm, will host its 29th annual Healthcare
Conference in New York on November 28-29, 2017.
The Piper Jaffray Healthcare Conference will showcase senior
management teams from nearly 275 leading public and private
companies delivering presentations to an audience of nearly 1,700,
including institutional investors, equity portfolio managers and
research analysts. The two-day event will also host more than 3,300
private one-on-one meetings with company management. Presenting
companies represent several healthcare sectors, including:
biotechnology, specialty pharmaceuticals, medical technology,
medical diagnostics, healthcare technology and services.
Highlighting the conference will be several panel discussions
featuring industry experts, physicians and academicians moderated
by Piper Jaffray healthcare senior research analysts:
- Diabetes PanelCo-Moderated by
Matt O’Brien and JP McKim, CFA
- M&A, Partnership &
Investment in Pharma PanelModerated by Matt Hemsley
- Health.ai: Opportunities and
Challenges in the Application of Artificial Intelligence in
HealthcareModerated by Sean Wieland
- Emerging Treatment Options in
DermatologyModerated by David Amsellem
“As the healthcare industry is rapidly accelerating in
innovation and technology, we strive to offer our clients an
intimate experience with some of the industry’s key leaders,” said
Michael Cox, director of equity research at Piper Jaffray. “Through
company presentations, fireside chats, panel presentations and
one-on-one meetings, the conference offers a variety of experiences
for our clients to learn about and network with companies.”
Follow the conversation using the event hashtag #PJCHCC17
Company and investor participation in the conference is by
invitation only. Clients interested in attending should contact
their Piper Jaffray representative. General and research-related
media inquiries should be directed to
analystmediarelations@pjc.com. All other media inquiries should be
directed to Pamela Steensland at pamela.k.steensland@pjc.com.
Information as of November 20, 2017. Subject to change.
About Piper JaffrayPiper Jaffray Companies (NYSE: PJC) is
a leading investment bank and asset management firm. Securities
brokerage and investment banking services are offered in the U.S.
through Piper Jaffray & Co., member SIPC and FINRA; in Europe
through Piper Jaffray Ltd., authorized and regulated by the U.K.
Financial Conduct Authority; and in Hong Kong through Piper Jaffray
Hong Kong Limited, authorized and regulated by the Securities and
Futures Commission. Asset management products and services are
offered through five separate investment advisory affiliates―U.S.
Securities and Exchange Commission (SEC) registered Advisory
Research, Inc., Piper Jaffray Investment Management LLC, PJC
Capital Partners LLC and Piper Jaffray & Co., and
Guernsey-based Parallel General Partners Limited, authorized and
regulated by the Guernsey Financial Services Commission.
© 2017 Piper Jaffray Companies. 800 Nicollet Mall, Suite 1000,
Minneapolis, Minnesota 55402-7036
Follow Piper Jaffray: LinkedIn | Facebook | Twitter
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171122005594/en/
Piper Jaffray CompaniesPamela Steensland,
612-303-8185pamela.k.steensland@pjc.com
Piper Jaffray Companies (NYSE:PJC)
Historical Stock Chart
From Sep 2024 to Oct 2024
Piper Jaffray Companies (NYSE:PJC)
Historical Stock Chart
From Oct 2023 to Oct 2024